215 related articles for article (PubMed ID: 11681241)
1. [Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
Hosomi Y; Shibuya M
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1352-6. PubMed ID: 11681241
[TBL] [Abstract][Full Text] [Related]
2. [Etoposide in the treatment of small-cell lung cancer].
Ueoka H
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1920-4. PubMed ID: 8978798
[TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
4. Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
Bregni M; Pedrazzoli P
J Natl Cancer Inst; 2009 Jan; 101(1):67; author reply 67-8. PubMed ID: 19116385
[No Abstract] [Full Text] [Related]
5. A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
Romaguera JE; Rodriguez MA; Hagemeister FB; McLaughlin P; Swan F; Moore DF; Sarris AH; Younes A; Hill D; Cabanillas F
Invest New Drugs; 1994; 12(3):217-22. PubMed ID: 7896540
[TBL] [Abstract][Full Text] [Related]
6. MINE-ESHAP salvage therapy for recurrent and refractory lymphomas.
Cabanillas F; Rodriguez MA
Semin Hematol; 1994 Apr; 31(2 Suppl 3):30. PubMed ID: 8073305
[No Abstract] [Full Text] [Related]
7. Ifosfamide in small cell lung cancer.
Einhorn LH
Semin Oncol; 1989 Feb; 16(1 Suppl 3):19-21. PubMed ID: 2539644
[TBL] [Abstract][Full Text] [Related]
8. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA
Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195
[TBL] [Abstract][Full Text] [Related]
10. [Ifosfamide and adriamycin after induction with cisplatin and etoposide (VP-16) in pulmonary microcytoma. Preliminary results].
Antilli A; Cruciani AR; Nunziati F; Orazi D; Portalone L; Signora M; Salvati F
G Ital Chemioter; 1985; 32(1):71-2. PubMed ID: 3007254
[No Abstract] [Full Text] [Related]
11. Diseases desperate grown.
Bunn PA
J Natl Cancer Inst; 2008 Apr; 100(8):520-1. PubMed ID: 18398099
[No Abstract] [Full Text] [Related]
12. Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
Edelman MJ; Chansky K; Gaspar LE; Leigh B; Weiss GR; Taylor SA; Crowley J; Livingston R; Gandara DR
J Clin Oncol; 2004 Jan; 22(1):127-32. PubMed ID: 14701775
[TBL] [Abstract][Full Text] [Related]
13. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
Behera D; Jindal SK; Sharma SC
Indian J Chest Dis Allied Sci; 1995; 37(1):15-9. PubMed ID: 16892733
[TBL] [Abstract][Full Text] [Related]
14. [Maintenance chemotherapy for small-cell lung cancer. A new publication].
Margery J; Le Moulec S; Grassin F; Guigay J; Vaylet F; L'her P
Rev Pneumol Clin; 2003 Jun; 59(3):179-80. PubMed ID: 13130207
[No Abstract] [Full Text] [Related]
15. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
16. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D
Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659
[TBL] [Abstract][Full Text] [Related]
17. [Nogitecan hydrochloride].
Negoro S
Nihon Rinsho; 2002 May; 60 Suppl 5():370-3. PubMed ID: 12101691
[No Abstract] [Full Text] [Related]
18. [Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
Chen LK; Xu GC; Liang Y; Yang QY; Zhang LN
Ai Zheng; 2006 Apr; 25(4):505-8. PubMed ID: 16613690
[TBL] [Abstract][Full Text] [Related]
19. Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
Tas F; Derin D; Guney N; Camlica H; Aydiner A; Topuz E
Lung Cancer; 2007 Jul; 57(1):79-83. PubMed ID: 17383768
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
Gridelli C; Curcio C; Iaffaioli RV; Brancaccio L; D'Aprile M; Gebbia V; Rossi A; Tortoriello A; Veltri E; Maione P; Barbarisi A; Gallo C; Guida C; Perrone F
Anticancer Res; 2001; 21(6A):4179-83. PubMed ID: 11911315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
